Get the Stockscreener App
0.2458
1.25%
-0.0031
Pre-market:
.25
0.0042
+1.71%
Vistagen Therapeutics Inc Stock (VTGN) Forecast
The Vistagen Therapeutics Inc (VTGN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $19.33, representing a +7,763% increase from the current price of $0.2458. The highest analyst price target is $19.89, and the lowest is $18.76.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VTGN Price Target
Average 21.07
(+8,473% Upside)
Is Vistagen Therapeutics Inc (VTGN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 29.63 | Buy |
| STOCH(9,6) | 48.36 | Neutral |
| STOCHRSI(14) | 3.6595 | Buy |
| MACD(12,26) | -0.039 | Sell |
| ADX(14) | 22.69 | Neutral |
| William %R | -92.52 | Buy |
| CCI(14) | -232.16 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.5845
Sell
|
0.5226
Sell
|
| MA20 |
0.5773
Sell
|
0.5664
Sell
|
| MA50 |
0.6016
Sell
|
0.6072
Sell
|
| MA100 |
0.594
Sell
|
0.8154
Sell
|
| MA200 |
1.726
Sell
|
1.2567
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, VTGN could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on VTGN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 29.63 indicates that VTGN is oversold. This indicates that VTGN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 48.36 indicates that VTGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 3.6595 indicates that VTGN is oversold. This suggests that VTGN price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.69 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -232.16 indicates that VTGN is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term VTGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Vistagen Therapeutics Inc financial reports and earnings history, Vistagen Therapeutics Inc (VTGN) stock could reach $10.26 by 2030, $87.03 by 2040 and $110.90 by 2050. See the projected annual prices until 2050 of the Vistagen Therapeutics Inc stock below:
- Vistagen Therapeutics Inc (VTGN) is expected to reach an average price of $68.77 in 2035, with a high prediction of $68.90 and a low estimate of $67.18. This indicates an $27,880% rise from the last recorded price of $0.2458.
- Vistagen Therapeutics Inc (VTGN) stock is projected to chart a bullish course in 2040, with an average price target of $87.02, representing an $35,304% surge from its current level. The forecast ranges from a conservative $86.04 to a sky-high $87.03.
- Our analysts predict Vistagen Therapeutics Inc (VTGN) to jump 41,351% by 2045, soaring from $100.64 to an average price of $101.89, potentially reaching $101.91. While $100.64 is the low estimate, the potential upside is significant.
- Vistagen Therapeutics Inc (VTGN) stock is expected to climb by 2050, reaching an average of $110.79, a $44,973% jump from its current level. However, a wide range of estimates exists, with high and low targets of $110.90 and $109.34, respectively, highlighting the market's uncertainty.
Vistagen Therapeutics Inc Stock (VTGN) Year by Year Forecast
Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2026
The predicted value for Vistagen Therapeutics Inc (VTGN) in 2026 is set at an average of $18.01. Estimates vary from a peak of $21.93 to a trough of $14.08, indicating an +7,225% surge from the present price of $0.2458.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2026 | $19.80 | $18.76 | $19.89 | +7,955% |
| September, 2026 | $20.63 | $19.75 | $20.99 | +8,294% |
| October, 2026 | $20.74 | $20.31 | $20.94 | +8,338% |
| November, 2026 | $21.43 | $20.72 | $21.54 | +8,617% |
| December, 2026 | $21.67 | $21.47 | $21.93 | +8,717% |
Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Vistagen Therapeutics Inc (VTGN) is $23.42, with a high forecast of $25.22 and a low forecast of $21.61. This indicates an +9,427% increase from the last price of $0.2458.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.67 | $21.61 | $21.91 | +8,716% |
| February, 2027 | $21.97 | $21.62 | $22.18 | +8,836% |
| March, 2027 | $22.20 | $21.76 | $22.21 | +8,932% |
| April, 2027 | $22.48 | $22.20 | $22.74 | +9,044% |
| May, 2027 | $22.66 | $22.33 | $22.85 | +9,121% |
| June, 2027 | $22.93 | $22.74 | $23.13 | +9,228% |
| July, 2027 | $23.37 | $22.97 | $23.39 | +9,406% |
| August, 2027 | $23.94 | $23.37 | $24.24 | +9,641% |
| September, 2027 | $24.15 | $23.86 | $24.23 | +9,724% |
| October, 2027 | $24.50 | $24.25 | $24.57 | +9,868% |
| November, 2027 | $24.87 | $24.54 | $24.95 | +10,019% |
| December, 2027 | $24.63 | $24.30 | $25.22 | +9,921% |
Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2028
In 2028, Vistagen Therapeutics Inc (VTGN) is projected to reach an average price of $28.85, with a high projection of $32.97 and a low estimate of $24.73. This indicates an +11,637% rise from the last price of $0.2458.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $25.08 | $24.73 | $25.09 | +10,102% |
| February, 2028 | $25.48 | $25.17 | $25.50 | +10,267% |
| March, 2028 | $26.00 | $25.58 | $26.01 | +10,476% |
| April, 2028 | $26.41 | $26.09 | $26.44 | +10,645% |
| May, 2028 | $26.92 | $26.52 | $26.96 | +10,853% |
| June, 2028 | $27.42 | $27.02 | $27.45 | +11,057% |
| July, 2028 | $27.86 | $27.52 | $28.02 | +11,234% |
| August, 2028 | $28.35 | $27.96 | $28.39 | +11,433% |
| September, 2028 | $28.78 | $28.45 | $28.80 | +11,607% |
| October, 2028 | $29.19 | $28.87 | $29.21 | +11,775% |
| November, 2028 | $29.73 | $29.30 | $29.75 | +11,997% |
| December, 2028 | $31.90 | $29.80 | $32.97 | +12,877% |
Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2029
The 2029 price forecast for Vistagen Therapeutics Inc Stock (VTGN) is $32.19 on average, with a high prediction of $55.49 and a low estimate of $8.8856. This represents an +12,994% increase from the previous price of $0.2458.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $32.38 | $31.89 | $32.44 | +13,074% |
| February, 2029 | $36.41 | $32.30 | $55.49 | +14,715% |
| March, 2029 | $37.37 | $35.82 | $38.66 | +15,102% |
| April, 2029 | $35.28 | $34.76 | $37.46 | +14,255% |
| May, 2029 | $34.95 | $34.83 | $35.88 | +14,118% |
| June, 2029 | $36.46 | $35.04 | $36.60 | +14,731% |
| July, 2029 | $38.37 | $36.59 | $38.71 | +15,511% |
| August, 2029 | $38.55 | $38.06 | $39.31 | +15,582% |
| September, 2029 | $39.13 | $38.42 | $39.64 | +15,821% |
| October, 2029 | $38.90 | $38.53 | $39.72 | +15,725% |
| November, 2029 | $39.92 | $38.98 | $40.68 | +16,139% |
| December, 2029 | $8.9228 | $8.8856 | $40.41 | +3,530% |
Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2030
Vistagen Therapeutics Inc Stock (VTGN) is expected to reach an average price of $14.51 in 2030, with a high forecast of $19.91 and a low forecast of $9.1158. This signifies an +5,805% surge from the last price of $0.2458.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.19 | $9.1158 | $10.26 | +4,047% |
| February, 2030 | $10.96 | $10.40 | $11.00 | +4,359% |
| March, 2030 | $11.72 | $11.12 | $11.79 | +4,669% |
| April, 2030 | $12.69 | $11.84 | $12.87 | +5,062% |
| May, 2030 | $14.12 | $12.89 | $14.21 | +5,647% |
| June, 2030 | $15.06 | $14.23 | $15.39 | +6,027% |
| July, 2030 | $15.33 | $15.07 | $15.92 | +6,135% |
| August, 2030 | $16.64 | $15.53 | $16.90 | +6,670% |
| September, 2030 | $17.35 | $16.71 | $17.45 | +6,957% |
| October, 2030 | $18.43 | $17.54 | $18.56 | +7,397% |
| November, 2030 | $19.04 | $18.59 | $19.19 | +7,647% |
| December, 2030 | $19.84 | $19.13 | $19.91 | +7,973% |
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):